Caliber Imaging & Diagnostics, Inc. (USD) Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Caliber Imaging & Diagnostics, Inc. (USD) Active

100 Burtt Road, Andover, MA, US, 01810

Stock Price USD

Price Change

Last Dividend USD

LCDX's stock peer is BBAL (New York Health Care, Inc.)

LCDX's stock peer is FPMI (FluoroPharma Medical, Inc.)

LCDX's stock peer is LPTI (Longport, Inc.)

LCDX's stock peer is NMRD (Nemaura Medical Inc.)

LCDX's stock peer is NMXS (Net Medical Xpress Solutions, Inc.)

LCDX's stock peer is NWCI (NewCardio, Inc.)

LCDX's stock peer is RBSH (Rebus Holdings, Inc.)

LCDX's stock peer is ULGX (Urologix, Inc.)

LCDX's stock peer is UPH (UpHealth, Inc.)

LCDX's stock peer is VIVE (Viveve Medical, Inc.)

Healthcare Medical - Devices

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions